ClinicalTrials.Veeva

Menu

Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

R

Rambam Health Care Campus

Status

Completed

Conditions

Pancreatic Cancer

Treatments

Device: PET-CT

Study type

Observational

Funder types

Other

Identifiers

NCT00294840
PETDCTIL

Details and patient eligibility

About

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age>18
  • newly diagnosed untreated aggressive NHL
  • newly diagnosed untreated cancer of pancreas

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems